SCHEMBL8995796

SCHEMBL8995796

CCc1cc(C)ccc1C(=O)OC(C)=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.40
HSD17B1 P14061 1/20 0.39
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA7 P43166 1/20 0.37
CA9 Q16790 1/20 0.37
CA14 Q9ULX7 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 2/20 0.36
HSD17B10 Q99714 2/20 0.36
RAB9A P51151 2/20 0.36
HPGD P15428 1/20 0.36
TAS1R3 Q7RTX0 1/20 0.35
TAS1R1 Q7RTX1 1/20 0.35
TAS1R2 Q8TE23 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12488919 0.82 NR4A2 (0.49) LMNACA12CA1CA2CA7
SCHEMBL18677456 0.82 TSHR (0.55) LMNACA12CA1CA2CA7
SCHEMBL5567273 0.81 FLT1 (0.48) LMNAHSD17B1CYP1A2CYP2C9CYP2C19
SCHEMBL3089078 0.80 ALDH1A1 (0.47) ALDH1A1HSD17B10RAB9AHPGDNPC1
SCHEMBL9217873 0.80 HSD17B1 (0.58) LMNAHSD17B1CYP1A2CYP2C9CYP2C19
SCHEMBL5490646 0.79 PSMB5 (0.38) LMNAHSD17B1CYP1A2CYP2C19SMN1; SMN2
SCHEMBL28552670 0.79 NPC1 (0.42) LMNACYP1A2CYP2C19SMN1; SMN2KDM4E
SCHEMBL7433331 0.78 CYP2A6 (0.41) HSD17B1ALDH1A1RAB9A
SCHEMBL31534041 0.77 HSD17B1 (0.42) LMNAHSD17B1CYP1A2CYP2C9CYP2C19
SCHEMBL537039 0.77 ALDH1A1 (0.49) LMNACYP1A2CYP2C9ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5554617-A Method for treating cancer with 6-aryl pyrimidine compounds THE UPJOHN COMPANY (US) 1996-09-10 US disclosed
US-5434157-A Active against herpes, hepatitis, papovavirus THE UPJOHN COMPANY (US) 1995-07-18 US disclosed
US-5002951-A 2-amino-5-halo-4-pyrimidinol for bactericides and antiprotozoa agent THE UPJOHN COMPANY (US) 1991-03-26 US disclosed
US-4665077-A IMMUNOREGULATORY AGENTS THE UPJOHN COMPANY (US) 1987-05-12 US disclosed
US-4619933-A 6-aryl pyrimidines for treating aplastic anemia THE UPJOHN COMPANY (US) 1986-10-28 US disclosed
US-4543248-A Method for immunoregulation with 6-aryl pyrimidine compounds THE UPJOHN COMPANY (US) 1985-09-24 US disclosed
US-4507302-A Method for treating arthritis with 6-aryl pyrimidine compounds THE UPJOHN COMPANY (US) 1985-03-26 US disclosed